Cargando…
Extracellular and intracellular small-molecule galectin-3 inhibitors
Galectin-3 is a carbohydrate binding protein which has important roles in cancer and immunity. Potent galectin-3 inhibitors have been synthesized, for experimental purposes and potential clinical use. As galectin-3 is implicated in both intra- and extracellular activities, permeability of galectin-3...
Autores principales: | Stegmayr, John, Zetterberg, Fredrik, Carlsson, Michael C., Huang, Xiaoli, Sharma, Gunjan, Kahl-Knutson, Barbro, Schambye, Hans, Nilsson, Ulf J., Oredsson, Stina, Leffler, Hakon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379368/ https://www.ncbi.nlm.nih.gov/pubmed/30778105 http://dx.doi.org/10.1038/s41598-019-38497-8 |
Ejemplares similares
-
Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans
por: Stegmayr, John, et al.
Publicado: (2016) -
Aromatic heterocycle galectin-1 interactions for selective single-digit nM affinity ligands
por: Peterson, Kristoffer, et al.
Publicado: (2018) -
Discovery and
Optimization of the First Highly Effective
and Orally Available Galectin-3 Inhibitors for Treatment of
Fibrotic Disease
por: Zetterberg, Fredrik R., et al.
Publicado: (2022) -
Aminopyrimidine–galactose hybrids are highly selective galectin-3 inhibitors
por: Dahlqvist, Alexander, et al.
Publicado: (2019) -
Mutational Tuning of Galectin-3 Specificity and Biological Function
por: Salomonsson, Emma, et al.
Publicado: (2010)